Previous close | 0.1500 |
Open | 0.6500 |
Bid | 0.5500 |
Ask | 0.6500 |
Strike | 2.50 |
Expiry date | 2024-09-20 |
Day's range | 0.6500 - 0.6500 |
Contract range | N/A |
Volume | |
Open interest | 196 |
Compugen Ltd. ( NASDAQ:CGEN ) just released its first-quarter report and things are looking bullish. Revenue crushed...
Compugen (CGEN) delivered earnings and revenue surprises of 20% and 8.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced financial results for the first quarter ended March 31, 2024 and provided a corporate update.